GovChime
AWARDDEFINITIVE CONTRACTSmall business

Definitive contract 75N91019C00022BIOMARKER STRATEGIES LLC

Overview

Award facts

Net obligations
$1.35M
$1,345,018of $1.35M potential value
Outlays (paid to date)
$185.02K
$185.02K paid of $1.35M obligated$185,018
Period of performance
Sep 16, 2019 to Aug 15, 2023
Ended
Modifications
6
Latest action Aug 15, 2023
Contract type
Definitive contract
PIID 75N91019C00022

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

SBIR TOPIC 354: A NOVEL PREDICTIVE TEST FOR RESPONSE TO COMBINATION IMMUNOTHERAPIES FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)

Dates and value

Award date
Signed on Sep 12, 2019
Potential end of performance
Aug 14, 2023
Current value
$1,345,018Base and exercised options
Potential value (if all options are exercised)
$1,345,018

Obligations by fiscal year of action

  • FY2023: -$153,009 (de-obligation)
  • FY2019: $1,498,027

Total across 2 fiscal years: $1,345,018

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 15, 2023. View on USAspending · Recipient on SAM.gov

Recipient

LocationDERWOOD, MD
UEIMMRCBR1M7WN5
CAGE code4UPX8
Business sizeSmall businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt

Business types and certifications

For-profit organizationLimited liability companyCorporation (not tax-exempt)

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. National Institutes Of Health
  3. NIH NCI
Funded from
National cancer institute (0849)Program activities075-0849Federal accounts (agency financial reports)

Place of performance

Place of performance
Derwood, Montgomery County, Maryland 20855-2734
Congressional district (place of performance)
MD-08As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competition after exclusion of sourcesD
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
Small business set aside - totalSBA
Contract pricing
Firm fixed priceJ
Offers received
2

Solicitation and notices

Solicitation ID
BAAN44CO8900449(as reported)
Solicitation date
Oct 4, 2018

Contract details

Subcontracting plan
Plan not requiredB
Major program
A novel predictive test for response to combination immunotherapies for patients with non-small cell
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/services procedures not usedD
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 12, 2019Base obligation at award: $1,498,027
Latest action
Aug 15, 2023 — Supplemental agreement (within scope)Modification P00006; obligation change -$153,009
Latest substantive action
Aug 15, 2023 — Supplemental agreement (within scope)Modification P00006; obligation change -$153,009
Actions by type
  • Base award1
  • Supplemental agreement (within scope)5
  • Other administrative action1
7 actions recorded, Sep 12, 2019 to Aug 15, 2023; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
No
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$153,009
Latest action: change in base and all options
-$153,009

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No
Research program (SBIR/STTR)
Small business innovation research program phase ii actionSR2
Walsh-Healey Act (materials and supplies)
No
Construction wage rates (Davis-Bacon)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7529
Contracting office code
75N910
Transactions recorded under this award key
7

Funding

Funding agency code
7500
Funding sub-tier code
7529
Funding office code
75N910
Treasury accounts
  • 075-2019/2019-0849-000
Object classes
  • 25.5: Research and development contracts
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression